Publications by authors named "Sandy Nielsen"

Claim this Profile
L
Lessons learned: Using a Three-Step Model of Planned Change for nursing curricular revision.
Theresa Adelman-Mullally, Sandy Nielsen, Carolina Posada Ford, Kim Astroth, Seon Yoon Chung

J Prof Nurs· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Planned change in modern hierarchical organizations: A three-step model.
Theresa Adelman-Mullally, Sandy Nielsen, Seon Yoon Chung

J Prof Nurs· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life improvement in patients treated with degarelix versus leuprorelin for advanced prostate cancer.
Dawn Lee, Sandy Kildegaard Nielsen, Marjolijn van Keep, Fredrik Andersson, Damien Greene

J Urol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4 g or twice-daily 2g mesalazine dosing.
Mark P Connolly, Johan P Kuyvenhoven, Maarten J Postma, Sandy K Nielsen

J Crohns Colitis· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom.
Dawn Lee, Joshua Porter, Daniel Gladwell, Nic Brereton, Sandy K Nielsen

J Med Econ· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancer.
Hind T Hatoum, E David Crawford, Sandy Kildegaard Nielsen, Swu-Jane Lin, Dennis C Marshall

Expert Rev Pharmacoecon Outcomes Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer.
Hind T Hatoum, E David Crawford, Sandy Kildegaard Nielsen, Swu-Jane Lin, Dennis C Marshall

Expert Rev Pharmacoecon Outcomes Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis.
Chris D Poole, Mark P Connolly, Sandy Kildegaard Nielsen, Craig J Currie, Philippe Marteau

J Crohns Colitis· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial.
Mark P Connolly, Sandy K Nielsen, Craig J Currie, Philippe Marteau, Chris S J Probert

J Crohns Colitis· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial.
Mark P Connolly, Sandy K Nielsen, Craig J Currie, Chris D Poole, Simon P L Travis

J Crohns Colitis· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic sales and the prevalence of symptoms of asthma, rhinitis, and eczema: The International Study of Asthma and Allergies in Childhood (ISAAC).
Sunia Foliaki, Sandy Kildegaard Nielsen, Bengt Björkstén, Erika Von Mutius, Soo Cheng

Int J Epidemiol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis